Matinas BioPharma Holdings, Inc. (MTNB) income statement
MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.80−0.01 (-1.26%)
Close on Nov 20, 2026Market cap $11.75MP/E –Yield –
Matinas BioPharma Holdings, Inc. financial ratios
See a number that looks wrong?